Such a low bar (14>11d) discharge with Remdesivir - and continually mutating SARS-COV-2 - as stressed last night on 60 Minutes / where therapeutics we’re stressed over vaccines- will make HGEN behave better than an early NASH breakthrough -Intercept - as soon as EUA is approved by EOY-Parabolic with 1st day news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.